Sandoz receives $137 million in fight against generic hypertension drugs

From the Law360 Editors (September 13, 2024, 8:28 p.m. EDT) — United Therapeutics Corp. owes Sandoz Inc. $137.2 million for conduct that violated a previous settlement agreement between the parties and effectively blocked sales of the generic version of an injectable drug used to treat high blood pressure made by Sandoz, a federal judge in New Jersey ruled….

Law360 is there, so you are too.

With a Law360 subscription, you'll always be up to date on current legal issues, trends and developments so you can act quickly and confidently. Over 200 articles are published daily on more than 60 topics, industries, legal areas and practice areas.

A Law360 subscription includes features such as

• Daily newsletter
• Expert analysis
• MobileApp
• Advanced search options
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.